Press release
Non-covid mRNA Vaccine and Therapeutics Market Exclusive Report on the Latest Revenue and Future Scope
The Global Non-covid mRNA Vaccine and Therapeutics Market is valued at US$ 370.0 Mn in 2024, and it is expected to reach US$ 1,684.80 Mn by 2031, with a CAGR of 24.20% during the forecast period of 2024-2031.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2814
Advances in mRNA technology have significantly accelerated progress in therapeutic and vaccine development, positioning the non-COVID mRNA vaccines and therapeutics market for substantial growth. This platform leverages synthetic messenger RNA to instruct cells to produce targeted proteins that can prevent, manage, or treat a broad spectrum of conditions, including infectious diseases, cancer, and select genetic disorders.
The scope of applications for non-COVID mRNA-based therapies is extensive and highly impactful. mRNA vaccines are under active development for infectious diseases such as influenza, HIV, and Zika, with the objective of generating strong and durable immune responses. In the field of oncology, personalized mRNA vaccines designed to encode tumor-specific antigens are being developed to stimulate the immune system to identify and eliminate cancer cells based on individual patient tumor characteristics.
List of Prominent Players in the Non-covid mRNA Vaccine and Therapeutics Market:
• CureVac
• Anima Biotech
• Arcturus Therapeutics
• BioNTech (Pfizer)
• eFFECTOR Therapeutics, Inc.
• eTheRNA
• Ethris (AstraZeneca)
• H3 Biomedicine Inc. (Eisai Inc.)
• In-Cell-Art
• Ionis Pharmaceuticals, Inc.
• Kernal Biologics
• Moderna
• RNAimmune (Sirnaomics)
• Silence Therapeutics
• Skyhawk Therapeutics, Inc.
• Stemirna Therapeutics Co., Ltd.
• Tiba Biotechnology
• Translate Bio Sanofi)
• Ziphius Therapeutics NV
Market Dynamics:
Drivers:
The expansion of the non-COVID mRNA vaccines and therapeutics market is largely driven by technological progress that has improved product stability, delivery efficiency, and therapeutic effectiveness, particularly through advancements in lipid nanoparticle (LNP) delivery systems. The broad and growing range of applications including infectious disease prevention, personalized oncology treatments, and therapies for genetic disorders continues to widen the market opportunity. Furthermore, the rapid development and scalable manufacturing capabilities demonstrated during the COVID-19 pandemic have reinforced mRNA technology as a dependable platform for large-scale therapeutic production.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2814
Challenges:
Despite strong momentum, the market faces several technical and operational constraints. Fragmented manufacturing workflows that rely on multiple external suppliers often lead to inefficiencies and delays, posing challenges especially for smaller organizations with limited operational capacity. In addition, constrained access to GMP-compliant raw materials can create supply bottlenecks.
Regional Trends:
North America holds a leading position in the non-COVID mRNA vaccines and therapeutics market, supported by a well-developed research and development ecosystem, the presence of major pharmaceutical and biotechnology companies, and strong academic research capabilities. This integrated environment promotes innovation, strategic partnerships, and sustained investment in mRNA technologies.
Recent regulatory approvals, such as the U.S. FDA authorization of Moderna's mRNA-based RSV vaccine for older adults, highlight the region's continued leadership. Additionally, supportive regulatory policies and robust public-private collaborations are accelerating clinical progress and the commercialization of next-generation mRNA therapies.
Recent Developments:
• In Jan 2023, Moderna, Inc. announced a definitive agreement to acquire OriCiro for $85 million. This acquisition provides Moderna with advanced tools for cell-free synthesis and amplification of plasmid DNA, a crucial component in the mRNA manufacturing process.
• In Aug 2021, Sanofi entered into a definitive agreement to acquire Translate Bio, a clinical-stage mRNA therapeutics company, for $38.00 per share in cash, totaling approximately $3.2 billion. Both companies' Boards of Directors have unanimously approved the transaction, aiming to accelerate Sanofi's development of mRNA-based therapeutics and vaccines.
For More Customization @
https://www.insightaceanalytic.com/customisation/2814
Segmentation of Non-covid mRNA Vaccine and Therapeutics Market-
Non-covid mRNA Vaccine and Therapeutics Market- By Product Type
• mRNA Therapeutic
• mRNA Vaccines
Non-covid mRNA Vaccine and Therapeutics Market- By Therapeutic Area
• Infectious Diseases
o Influenza
o Respiratory Syncytial Virus (RSV)
o Cytomegalovirus
o Others
• Oncological Disorders
• Other Disorders
Non-covid mRNA Vaccine and Therapeutics Market- By Route of Administration
• Intravenous
• Intramuscular
• Intranasal
• Others
Non-covid mRNA Vaccine and Therapeutics Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Get More Information @
https://www.insightaceanalytic.com/report/non-covid-mrna-vaccine-and-therapeutics-market/2814
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: info@insightaceanalytic.com
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-covid mRNA Vaccine and Therapeutics Market Exclusive Report on the Latest Revenue and Future Scope here
News-ID: 4349186 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Nano Flow Cytometry(nFCM) Market Report Latest Trends and Future Opportunities A …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Nano Flow Cytometry(nFCM) Market Size, Share & Trends Analysis Report By Type (
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by…
Micro Combined Heat and Power Market Current Scenario with Future Aspect Analysi …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Micro Combined Heat and Power Market Size, Share & Trends Analysis Report By Application (Residential, Commercial), Type (Engine-Based, Fuel Cell-Based), Technology (Internal Combustion Engine, PEMFC, Rankine Cycle Engine, Stirling Engine, SOFC)- Market Outlook And Industry Analysis 2031"
The Global Micro Combined Heat and Power Market is valued at US$ 3.06 Bn in 2023, and it is…
Fuel Cell Commercial Vehicle Market Growth and Restrain Factors Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Fuel Cell Commercial Vehicle Market Size, Share & Trends Analysis Report By Vehicle (Light commercial vehicles, Medium commercial vehicles, Heavy commercial vehicles), Fuel Cell Technology (Proton exchange membrane, Alkaline fuel cells, Solid oxide fuel cells), Range (Short-range, Medium-range, Long-range), End User (Public transit, Construction and mining, Logistics & transportation, Others)- Market Outlook And Industry Analysis…
Medical Simulation Market Expansion Fueled by Technological Advancements and Ris …
Global Medical Simulation Market Size is valued at USD 3.24 Bn in 2025 and is predicted to reach USD 13.55 Bn by the year 2035 at a 15.5% CAGR during the forecast period for 2026 to 2035.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1605
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Medical Simulation Market are:
• Rising interest in non-invasive medical procedures
• Rising levels of sophisticated technology
• Greater…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
